Here are five things to know about the transaction:
1. Mr. Cole sold 40,367 shares at $17.86 per share, average price.
2. The total value of the transaction was $720,954.62.
3. Mr. Cole now directly owns 308 shares of the company, valued at around $5,500.88.
4. K2M traded up yesterday, hitting $19.85 per share.
5. The company’s market cap is $783.4 million.
More articles on orthopedic devices:
OsteoMed launches ankle fusion plating system
Mesoblast gets patent for mesenchymal precursor cell technology—7 things to know
K2M closes follow-on offering with $35M
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
